positive. Look forward to seeing the trial design. Any ideas when this would start and the funding stream? For the right performance status patients, folfirinox is the preferred regimen everywhere, not just US. Wonder if they’ll run this trial outside US too.
- Forums
- ASX - By Stock
- Ann: Type D Meeting Outcome With US Food And Drug Administration
ATX
amplia therapeutics limited
Add to My Watchlist
2.04%
!
24.0¢

positive. Look forward to seeing the trial design. Any ideas...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $93.52M |
Open | High | Low | Value | Volume |
24.0¢ | 24.0¢ | 23.0¢ | $1.394M | 5.895M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 580668 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 20109 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 580668 | 0.235 |
26 | 1160824 | 0.230 |
12 | 1227155 | 0.225 |
17 | 602534 | 0.220 |
3 | 48406 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 20109 | 1 |
0.245 | 56858 | 2 |
0.250 | 133142 | 4 |
0.255 | 268500 | 7 |
0.260 | 86800 | 3 |
Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online